New Update
Haffkine Biopharma to produce 22.8 crore doses per annum of COVID-19 vaccine Covaxin: In an order to boost COVID-19 vaccination and vaccinate the entire eligible population at the earliest, the domestic vaccine production is being steadily ramped up in the country with help from the Central government.
As part of this initiative, three public enterprises were being supported by the Department of Biotechnology under Atmanirbhar Bharat 3.0 Mission Covid Suraksha. These enterprises are the:
- Haffkine Biopharmaceutical Corporation Ltd, Mumbai,
- Indian Immunologicals Ltd, Hyderabad and
- Bharat Immunologicals & Biologicals Ltd, Bulandshahar, UP.